SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for ENvue Medical, Inc. (FEED) (CIK 0001326706) (FEED) — Jun 23, 2017

ENvue Medical, Inc. (FEED) (CIK 0001326706)
Date: June 23, 2017 · CIK: 0001326706 · Accession: 0000000000-17-022118

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-218871

Date
June 23, 2017
Author
/s/ Amanda Ravitz
Form
UPLOAD
Company
ENvue Medical, Inc. (FEED) (CIK 0001326706)

Letter

Mail Stop 3030 June 23, 2017 Brian Murphy Chief Executive Officer NanoVibronix, Inc. 9 Derech Hashalom Street Nesher, Israel 36651

Re: NanoVibronix, Inc. Registration Statement on Form S-1 Filed June 21, 2017 File No. 333-218871

Dear Mr. Murphy :

Our preliminary review of your registration statement indicates that it fails in numerous material respects to comply with the requirements of the Securities Ac t of 1933, the rules and regulations under that Act, and the requirements of the form. The financial statements do not comply with Rule 8 -08 of Regulation S -X. We will not perform a detailed examination of the registration statement and we will not issue comments.

If you were to request acceleration of the effective date of the registration statement in its present form, we would likely recommend that the Commission deny your request.

You may contact Tim Buchmiller at (202) 551 -3635 with any questions.

Sincerely,
/s/ Amanda Ravitz

Show Raw Text
Mail Stop 3030
June 23, 2017

Brian Murphy
Chief Executive Officer
NanoVibronix, Inc.
9 Derech Hashalom Street
Nesher, Israel 36651

Re: NanoVibronix, Inc.
 Registration Statement on Form S-1
 Filed  June 21, 2017
 File No.  333-218871

Dear Mr. Murphy :

Our preliminary review of your registration statement indicates that it fails in numerous
material respects to comply with the requirements of the Securities Ac t of 1933, the rules and
regulations under that Act, and the requirements of the form.  The financial statements do not
comply with Rule 8 -08 of Regulation S -X.  We will not perform a detailed examination of the
registration statement and we will not issue  comments.

If you were to request acceleration of the effective date of the registration statement in its
present form, we would likely recommend that the Commission deny your request.

You may contact Tim Buchmiller  at (202) 551 -3635 with any questions.

Sincerely,

 /s/ Amanda Ravitz

Amanda Ravitz
Assistant Director
Office of Electronics and Machinery

cc: Rick A. Werner, Esq.
 Haynes and Boone, LLP